🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

After 8 hours staring at tumor genotype-phenotype relationships, its very clear that the future of precision oncology will require more than genomics.

Overnight H&E cut and stain last night. Our histology team is hardcore.

Announcement! @noetik_ai team are excited to launch a powerful new second(!) platform that connects seamlessly with our human platform to add powerful discovery capabilities... See press release and thread below👇 businesswire.com/news/home/2023…

We are building one of the most significant oncology datasets in the industry, fit for purpose for AI, with seamless connectivity between human data and scaled in vivo functional genomics/pharmacology.

Perturb-map, developed by Icahn Genomics Institute Director Brian Brown, is on the move! NOETIK is pairing their multimodal human data atlas with the innovative in vivo functional genomics platform to power the development of precision cancer immunotherapies: 🧐businesswire.com/news/home/2023…

Unboxing first results from 650 genes in vivo tumor screens vs checkpoint, it’s beautiful.

NOETIK is presenting two posters this Friday at #SITC24! Connect with Lacey Padron for a full stack view of our platform from data to discovery, and Phoebe Guo for exciting work on Tertiary Lymphoid Structure biology. businesswire.com/news/home/2024…

1/ NOETIK team are live at #SITC24 showing off new biological discoveries using our foundation models for human cellular and tissue biology. Come along for a tour:

Announcing OCTO-VirtualCell (vc) a multi-scale, multimodal transformer trained to predict gene expression for a virtual cell in cellular contexts within patient tissue samples. Complete wth the Celleporter demo app to explore the data! 1/

We NOETIK built a new foundation model for spatial biology: OCTO-VirtualCell. This model is prompted to simulate single cell gene expression in "virtual cells," which are placed within real, intact patient tissue. Read about & explore these simulations below:

Powering precision cancer treatment with #AI. 💻🔬 go.aws/4lL0KHh Learn how NOETIK, together with #AWS & NVIDIA AI, is applying advanced machine learning techniques to develop novel immunotherapies that will save lives.

Debuting at #AACR2025: Perturb-map — a high-throughput in vivo platform for modeling patient immunotypes + mapping drug-genotype interactions at scale. -Poster #160 -Apr 27 | 2–5PM CT -Section 7

Presenting at #AACR2025: OCTO Virtual Cell – a foundation model trained on 40M+ spatially profiled cells to simulate immune cell states in the TME. - Poster #3652 -Apr 28 | 2–5PM CT -Section 45, Board 14

Inspiring talks showed how AI is transforming drug discovery, genomics & protein design. The future of medicine is being written in code. * Andrew White Andrew White 🐦‍⬛ (Cofounder FutureHouse) * Andrew Payne Andrew Payne (CEO E11 Bio) * Atray Dixit Atray Dixit (prev

We're proud to highlight Noetik’s latest research at the AACR Annual Meeting 2025! If you missed our posters at #AACR2025, you can find them here noetik.ai/aacr-2025

We’re proud to be featured in NVIDIA’s latest blog highlighting RAPIDS and the future of scalable single-cell analysis. At NOETIK, we're building first-in-class virtual cell models trained on hundreds of millions of cells worth of patient data. developer.nvidia.com/blog/driving-t…

We’re excited to announce the collaboration between Agenus and Noetik to Develop AI-Enabled Predictive Biomarkers for BOT/BAL Using Foundation Models of Virtual Cell Biology. Read more here:businesswire.com/news/home/2025…

Great coverage of our collaboration with Agenus to use Virtual Cell Models of patient biology to impact clinical success. Together, we are directing the most advanced AI in biology to tackle real therapeutics challenges for patients. genengnews.com/topics/artific…

started my new job! i will be doing a combination of ml engineering and writing at NOETIK. picture very related tldr: we are building foundation models of tumor microenvironments to: 1. stratify patients into responders/non responders for cancer therapy trials 2. inform

Great piece on what we’re building NOETIK from owl perspective! Welcome!